Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MDT vs GSK✓SelectedUSD · GSKMDT vs GSK performance historyLatest closeAs of-1.56%11/18
Stock and ETF performance explorer

MDT vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+62.8%
GSK return
+100.8%
Excess return
-38.0%
Maximum drawdown
-45.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.6%-1.3%-0.2%-1.0%
7D-0.9%-3.1%+2.3%+0.3%
30D+8.6%-0.9%+9.5%+8.9%
3M+10.3%-4.2%+14.4%+11.9%
6M+32.5%-1.6%+34.1%+33.1%
YTD+7.5%+2.6%+4.9%+5.9%
1Y+3.2%+6.2%-3.0%+0.2%
3Y+48.6%+55.0%-6.3%+20.5%
5Y+0.4%+42.8%-42.4%-17.1%
All+62.8%+100.8%-38.0%+12.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling